Riskpilot← Back to searchSign inGet full accessVasDeBlock medical ApS
APSActiveCVR 37525758Storkevænget 8Wholesale of pharmaceutical and medical goods · NACE 4646Est. 2016— employees
Revenue 2024
DKK 0
EBITDA margin
—
-36% vs 2023
Equity ratio
-8.7%
Financial strength
Net profit 2024
DKK -76K
-36% vs 2023
| Revenue | DKK 0 | — |
| EBITDA | DKK -76K | -36% |
| Net profit | DKK -76K | -36% |
| Total assets | DKK 68K | -25% |
| Equity | DKK -6K | -108% |
| Employees | — | — |
Legal name
VasDeBlock medical ApS
CVR number
37525758
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
10. marts 2016
Share capital
DKK 224.767
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med bestyrelsesformanden eller af den samlede bestyrelse
Company purpose
Selskabets formål er at drive virksomhed med udvikling og markedsføring af nye præventionsmetoder til mænd og hermed forbundet virksomhed
Address
Storkevænget 8
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 50 | 50 | 33 | 17 | 0 | 0 | 0 | 60 | 0 |
| Staff expenses | -0 | -15 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -90 | -118 | -33 | -33 | -247 | -68 | -97 | -56 | -76 |
| Depreciation & amort. | -15 | -15 | -15 | -15 | -15 | -15 | -15 | -0 | -0 |
| EBIT | -105 | -133 | -49 | -48 | -262 | -83 | -112 | -56 | -76 |
| Net financials | -0 | -1 | -0 | -0 | -1 | -0 | -0 | 0 | 0 |
| Profit before tax | -105 | -133 | -49 | -48 | -263 | -83 | -112 | -56 | -76 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | -105 | -133 | -49 | -48 | -263 | -83 | -112 | -56 | -76 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 194 | 267 | 115 | 71 | 112 | 51 | 32 | 91 | 68 |
| Equity | 97 | 164 | 118 | 70 | 74 | 51 | 32 | 70 | -6 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 74 |
| Short-term debt | 97 | 103 | -3 | 1 | 38 | 0 | -0 | 21 | 0 |
| Total debt | 97 | 103 | -3 | 1 | 38 | 0 | -0 | 21 | 74 |
EBITDA margin
-7632400.0%
This company
15.8%
Market median
-48306429% vs market
20162024
Equity ratio
-8.7%
This company
38.2%
Market median
-123% vs market
20162024
Return on equity
-7618600.0%
This company
18.4%
Market median
-41405535% vs market
20162024
Net profit margin
-7618600.0%
This company
8.1%
Market median
-94056890% vs market
20162024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20162024
Debt / equity
12.52×
This company
0.62×
Market median
-1919% vs market
20162024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-03-10 – 2016-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PJ Founder | Founder | 2016 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2016 | — | — | |
| Board of Directors | 2016 | — | — | |
| Board of Directors | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
HOLDINGSELSKABET TEG AF 2011 ApS | Company | 66.7% | 66.7% | 2016 |
| Individual | 5.0% | 5.0% | 2016 | |
BRUMMERSTEDT HOLDING ApS | Company | 5.0% | 5.0% | 2020 |
| Individual | 5.0% | 5.0% | 2016 | |
SOLTECH ApS | Company | 5.0% | 5.0% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of VasDeBlock medical ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peter Johansen Viereck | Founder | 0 companies |
| Einar Gjaldbæk Petersen | Board of Directors | 0 companies |
| Henrik Harboe | Board of Directors | 0 companies |
| Niels Bøggild Lindeburg | Board of Directors | 0 companies |
| Anders Brummerstedt-Madsen | Board of Directors | 0 companies |